Parkinson's Movement
13,536 members12,067 posts

Will Tasigna, an FDA-approved cancer drug, be the first drug to revere symptoms of Parkinson's and dementia?

At their best, drugs for Parkinson's disease (PD) only slow the progression of the disease. But now a small clinical trial has shown that a cancer drug already approved by the FDA may have the potential to reverse PD symptoms, both motor and non-motor. as well as symptoms of depression.

The new hope was announced at the recent meeting of the Society for Neuroscience by researchers at the Georgetown University Medical Center. Using a drug developed for leukemia patients, the scientists cut the dose, and gave it to 12 patients who had either advanced PD with dementia or the related Lewy body dementia.

Dr. Fernando Pagan, director of the Movement Disorders Program at Georgetown, spoke at a meeting I attended last week. He acknowledged that this study involved only a small sample, none of whom received a placebo. The gold standard element for drug efficacy trials is "double-blind," where neither participants nor investigators know who gets the drug and who gets the placebo.

He said a larger clinical trial is planned and hopefully will start in early 2016. I asked Dr. Pagan when, assuming the expanded trial went well, we might be able to begin using the drug. He estimated it would be 3 to 5 years.

For more on his potential breakthrough, see my blog post at bit.ly/1lDGMiT.

18 Replies
oldestnewest

Well, this is the best news i have heard in a long time.

3-5 yearss is not bad!!!

Thank you for sharing Gleeson!!

Hugs and love, Eva G.

:)

3 likes
Reply

Hi .

Is this study in the UK? Do you know,

My husband has advanced PD.

No dementia, though...

But at aged 76, wonder if it will become available, before its to late for him,

Thanks.. 😊

1 like
Reply

Study and follow-up expanded study are at Georgetown Hospital here in Washington, DC where I live. As I said in my post here and in my blog report, I asked Dr. Pagan, assuming the follow-up confirms the original findings, when might the drug be available. He said 3-5 years.

1 like
Reply

It's never too late as long as the person is otherwise healthy. At Baptist Hospital in Winston-Salem, North Carolina they've performed Bi-lateral DBS (both hemispheres of the brain during a single operation) on a 79 year old (man). At 55 now myself, I knew I couldn't go wrong by having it done. 1st side at 53 YOA and the 2nd side at 54 YOA. I get to walk my daughter down the isle now!

Reply

Yes we are in the uk to, doubt it will be available, for a long time, especially if it's expensive.

My husband also has other health issues besides PD, he's had two mini strokes and has heart stents and a pacemaker,

So he would not qualify I'm guessing.

He does not have dementia, but advanced Parkinson's

Reply

A one month supply of Tasigna for cancer costs $9,000. The drug maker, Novartis will hopefully have a payment plan for PwP.

2 likes
Reply

That's probably the cost for Leukemia which uses 800 mg instead of 100 mg. Tasigna (nilotinib) is a CYP3A4 liver enzyme substrate which means peperine, grapefruit juice, milk thistle, and ginkgo will increase the amount that gets to the blood stream. In particular bergamottin in grapefruit juice. It's an insecure if not dangerous game to try to do this, but getting the dose down to 25 mg could be expected, but not predictable individually. That would be $281 a month. If that $9000 is the price in the U.S. then you should get it in other countries for 3 times less.

1 like
Reply

As I reported on my blog, the Parkinson's/dementia study used 150 and 300 mg contrasted with 800 mg for leukemia. So the cost for us PWP's would only :-) be $2000 to $4000 a month

1 like
Reply

Does pharmaceutical pricing work in a way that has a straight line apportioning of cost according to dose? Or are patent drugs typically priced based on what the market will bear?

Most of the cost may be wrapped up in development, approval and marketing, with only small increases in cost being directly related to manufacture of the active component.

Don't know what history has shown, but it's worth asking the question.

Reply

Dr. Pagan is at Georgetown Hospital Center in D C.

Reply

Dr. Fernando L. Pagan

Associate Professor of Neurology

Georgetown University Hospital

Parkinson's Disease Center

3800 Reservoir Rd. NW, 7th Floor

Washington DC 20007

Office: (202)-444-8525

Dr Fernando L Pagan <FPOGAN01@gunet.georgetown.edu>

Reply

Thanks for the info. Great news. Read it in your blog post too.

Aging and Parkinson's and Me

parkinsonsand5htp.blogspot....

Reply

Gleeson, you said: "At their best, drugs for Parkinson's disease (PD) only slow the progression of the disease. "

May I ask what drugs you are referring to (I don't know of any)?

Thanks!

1 like
Reply

Carbidopa-Levodopa (i.e. Sinemet), the "gold standard" med that I take and I understand the same is true of other options being used by others.

Reply

GM1 with a phase 3 trial in 77 patients completed 5 years ago is already the first Parkinson's FDA-allowed drug that stops the disease from progressing. The problem is that pharmaceuticals aren't interested in it and it will take an enormous number of patients demanding it before it becomes affordable (it has to be derived from animal sources like sheep or cows).

Also ferriprox (iron chelator) is in trials with success indicated.

The nilotinib researchers need to at least publish something that supports their claims instead of going straight to the media.

2 likes
Reply

Interesting!

Reply

Any further news here re. Tasigna? I don't understand why it would take 3-5 years. It's safe, on the market already, get it out there people are desperate

Reply

Hello, is there any patient with the off-label (or on label) use of Tasignia who can report a positive effect?

Reply